PL EN

FDA: Nonclinical Evaluation for Anticancer Pharmaceuticals

16.02.2009
FDA:
Nonclinical Evaluation for Anticancer Pharmaceuticals
This guideline provides information for pharmaceuticals that are only intended to treat cancer in 69 patients with late stage or advanced disease regardless of the route of administration, including 70 both small molecule and biotechnology-derived pharmaceuticals. This guideline describes the 71 type and timing of nonclinical studies in relation to the development of anticancer 72 pharmaceuticals and references other guidance as appropriate.

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny